I-gel Plus Supraglottic Airway Device for Surgical Procedures in Prone Position

The I-gel Plus Supraglottic Airway Device for Elective Surgical Procedures in Prone Position

I-gel Plus is a novel supraglottic airway device that has been evaluated in various studies with high success and low complication rates. Feasibility of supraglottic airway devices (SGA) in patients undergoing surgery in prone position has been demonstrated in some pilot studies and case series; however, the evidence is still limited. It is currently uncertain, if the i-gel Plus facilitates appropriate ventilation in individuals undergoing elective surgery in prone position.

The primary aim of this single-center non-inferior study is to assess the leak fraction of the i-gel Plus in patients undergoing surgery in prone position and to compare it with data from an existing prospective control cohort in patients undergoing surgery in supine position. Secondary aims are to investigate the oropharyngeal seal pressure and other secondary outcome parameters and to compare them with the control cohort.

Study Overview

Study Type

Observational

Enrollment (Actual)

28

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hamburg, Germany, 20246
        • University Medical-Center Hamburg Eppendorf

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

patients undergoing elective surgery in prone position with i-gel Plus used for airway management

Description

Inclusion Criteria:

  • Patients scheduling for elective surgery in prone position
  • Planned airway management using a SGA
  • Adult patients (age 18-89 years)
  • ASA physical status 1-3

Exclusion Criteria:

  • Pregnant or breastfeeding women
  • Non-fasted patients
  • Increased risk of aspiration or other contraindications for supraglottic mask ventilation
  • Shared airway or intracavity open surgery
  • Body mass index (BMI) >35 kg/m2
  • Inability to understand or sign informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Surgery in prone position
Patients undergoing elective surgery in prone position with i-gel Plus used for airway management
Exposure: surgery in prone position
Surgery in supine position
Existing prospective control cohort with patients undergoing elective surgery in supine position with i-gel Plus used for airway management
Exposure: Surgery in supine position

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Leak fraction
Time Frame: 3 hours
Ventilation parameter - Leakage volume per tidal volume
3 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative complications
Time Frame: 24 hours postoperatively
Clinical assessment
24 hours postoperatively
Complications at the end of surgery
Time Frame: 3 hours
Clinical assessment
3 hours
Oropharyngeal seal pressure [cm H2O]
Time Frame: 3 hours
Clinical assessment - leak pressure with audible leak
3 hours
Leakage volume (ml)
Time Frame: 3 hours
Ventilation parameter - as displayed on the ventilator
3 hours
Tidal volume (ml)
Time Frame: 3 hours
Ventilation parameter - as displayed on the ventilator
3 hours
Inspiratory peak pressure (cm H2O)
Time Frame: 3 hours
Ventilation parameter - as displayed on the ventilator
3 hours
Positive endexpiratory pressure (PEEP) (cm H2O)
Time Frame: 3 hours
Ventilation parameter - as displayed on the ventilator
3 hours
Respiratory rate (1/min)
Time Frame: 3 hours
Ventilation parameter - as displayed on the ventilator
3 hours
Minute ventilation (l/min/kg)
Time Frame: 3 hours
Ventilation parameter -as displayed on the ventilator
3 hours
Endtidal CO2 [mmHg]
Time Frame: 3 hours
Ventilation parameter - as displayed on the ventilator
3 hours
Number of insertion attempts
Time Frame: 3 hours
Clinical assessment - SGA insertion attempts
3 hours
Insertion success rate (%)
Time Frame: 3 hours
Clinical assessment
3 hours
First-attempt insertion success rate (%)
Time Frame: 3 hours
Clinical assessment - successful placement in only one insertion attempt
3 hours
Necessity of adjustment maneuvers during the procedure
Time Frame: 3 hours
Clinical assessment
3 hours
Insertion time (sec)
Time Frame: 3 hours
Clinical assessment
3 hours
Lowest oxygen saturation (%)
Time Frame: 3 hours
Measured by pulse oximetry
3 hours
Difficulty of insertion
Time Frame: 3 hours
Clinical assessment on a scale between 1-5
3 hours
Ease of gastric tube insertion
Time Frame: 3 hours
Clinical assessment - rating on a scale from 1-5
3 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Martin Petzoldt, MD, University Medical Center Hamburg-Eppendorf: Universitatsklinikum Hamburg-Eppendorf

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2024

Primary Completion (Actual)

February 4, 2025

Study Completion (Actual)

February 4, 2025

Study Registration Dates

First Submitted

September 16, 2024

First Submitted That Met QC Criteria

September 16, 2024

First Posted (Actual)

September 19, 2024

Study Record Updates

Last Update Posted (Actual)

June 8, 2025

Last Update Submitted That Met QC Criteria

June 4, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2024-101343-BO-ff

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Airway Management

Clinical Trials on Exposure: prone position

Subscribe